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Use of “mother-and-child” Catheter in Complex Percutaneous Coronary
Intervention
Sun Jiaan, Lei sheng
Bethune International Peace Hospital
Objectives: Complex percutaneous coronary intervention often needs stronger back-
up force, which usually cannot gain from guiding catheter itself. The aim of this
study is to probe safety and efﬁcacy of “mother and child” catheter in complex
percutaneous coronary such as CTO, serious torturous and diffuse calciﬁcation
lesions.
Methods: Heartrail “mother and child” catheter (or ﬁve in six catheter) system is
made by Terumo company (Japan). It involves insertion of a ﬂexible tipped extra
length 120 cm 5 Fr guiding catheter through a standard 100 cm 6 Fr guiding catheter
so that its tip extends into the vessel allowing extra deep intubation and hence
increased backup support. The haemostatic valve was disconnected from the guide
catheter and the heartrail device was passed through the guide catheter into the target
vessel either over a coronary wire, or a wire and a balloon catheter with the balloon
un-inﬂated in the distal vessel. The haemostatic valve was then re-attached to the end
of the Heartrail catheter and the interventional procedure was performed in the usual
manner through the haemostatic valve. Intubation depth were depended by the backup
force needed.
Results: A total of 26 complex coronary lesions which failed cross by guide
wire, balloon catheter or stent with routine method were selected from June, 2008
to December, 2010 to treat with heart rail child catheters. Those leisions include 5
LAD (19%), 6 LCX (23%) and 15 RCA (58%). Among these leisions, 6 (23%)
were CTO, 15 (58%) associated with serious torturous, 10 (38%) associated
with proximal stent, 15 (58%) associated with serious calciﬁcation. Success was
achieved in 24 (92%) leisions with stent implanted. Both the 2 failure lesions
were because balloon cannot cross. Air embolism was found in one lesion with
normal blood ﬂow after artery blood injection. No artery perforation and dissec-
tion was found during the procedure. No death and reinfarction during 3 month
follow-up.
Conclusions: “mother and child” catheter system could increase backup
support and help implant distal stent when routine method failed in complex
percutaneous coronary intervention. It is safe and efﬁcient but should care about
air embolism.
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Safety and efﬁcacy of a novel technique in the use of fractional ﬂow reserve in
complex coronary artery lesions
He Wenming1, Wang Jian’an2, Sun Yong2, Zhou Zhong1, Mai Yifeng1, Li Changling2
1The Afﬁliated Hospital of Medicine School of Ningbo University, 2The Second
Afﬁliated Hospital of Zhejiang University School of Medicine
Objectives: This study was performed to evaluate the safety and efﬁcacy of a novel
technique in the use of FFR in complex coronary artery lesions.
Methods: There were 56 patients with complex coronary artery lesions who under-
went FFR from December 1, 2012 to May 1, 2014, and were divided into two groups:
a conventional technique group and a novel technique group. The novel technique
involves the use of a broken balloon and wire exchange within the coronary artery.
After FFR, ﬂuoroscopy time, contrast dye usage and FFR-related complications were
assessed.
Results: The results showed that ﬂuoroscopy time and contrast dye usage were
signiﬁcantly different (P<0.05) in all patients after FFR, especially the ﬂuoroscopy
time in the novel technique group (5.71.0) s vs. (10.12.1) s. The novel technique
was successfully performed in 30 patients, without any FFR-ralated complications.
However, the conventional technique was technique was failed in 3 patients of another
group, with 2 cases of coronary artery spasm.
Conclusions: In comparison to the conventional technique of FFR, the new technique
is more effective and safer.
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The comparison on prognosis of NSTEACS patients with or without diabetes by
PCI, CABG and medication
Ma Lufeng1, Ding Rongjing2, Hu Dayi2
1School of Public Health and Family Medicine, Capital Medical University,
2Heart Center, Peking University People’s Hospital
Objectives: To compare the prognosis of non-ST segment elevation acute coronary
syndromes patients (NSTEACS, including unstable angina pectoris and non-ST
segment elevation myocardial infarction) with or without diabetes by PCI, CABG and
medication.
Methods: All the patients with NSTEACS in Peking University People’s Hospital,
Beijing Dongzhimen Hospital, Hebei Cangzhou Central Hospital and Henan Luoyang
Central Hospital between January 1, 2003 and December 31, 2010 were consecutively
enrolled in this study. The enrolled patients were divided into PCI group, CABG
group and medical therapy group according to different treatment, as well as diabetes
team and Non-diabetes group according to whether he/she was diabetes. All of the
clinical data in hospitalization were recorded, and the medical therapy and clinicalC152 JACC Vol 64/16/Suppl C j October 16–1events were followed up. The clinical data and end-point events were compared, and
the impact factors on prognosis of NSTEASCS patients with or without diabetes were
analyzed.
Results: (1) 6,800 patients with non-ST segment elevation acute coronary syn-
dromes were enrolled, and 930 (13.7%) patients were lost to follow-up. 3,448
(50.7%) patients were treated with PCI, 1,474 (21.7%) patients were treated with
CABG and 1,878 (27.6%) patients were treated with medicine alone. (2) The all-
cause mortality of PCI, CABG and medication was 3.7% (126 cases), 4.2% (62
cases) and 3.7% (70 cases) separately, P¼0.6462; The MACE rate was 5.1% (176
cases), 4.4% (65 cases) and 6.5% (123 cases) separately P¼0.017. (3) Multivar-
iable logistic regression analysis showed that compared with medication group,
CABG reduced all-cause mortality risks of patients with NSTEACS signiﬁcantly
(CABG: HR¼0.227, 95% CI 0.105-0.487, P¼0.0001), while PCI cannot decrease
all-cause mortality risks of patients with NSTEACS (PCI: HR¼0.903, 95% CI,
0.613-1.33 P¼0.6057). CABG and PCI decrease MACE risks of patients with
NSTEACS (CABG: HR 0.418, 95%CI 0.267-0.653, P¼0.0001; PCI: PCI:
HR¼0.38, 95% CI, 0.282-0.511 P<0.0001). (4) Patients with NSTEACS were
divided in two groups: NSTEACS with diabetic group 1,734 (25.5%); and
NSTEACS with Non-diabetic group 5,066 (74.5%). The all-cause mortality rate of
diabetic patients was obviously higher than that of non-diabetic patients (5.9% vs
3.1%, P<0.0001), and MACE of diabetic group was signiﬁcantly higher than that
of Non-diabetic group (7.7% vs. 4.6%, P<0.0001). Multivariable logistic
regression analysis showed that compared with Non-diabetic group, the factor of
diabetes was the independent hazard factor of all-cause mortality (HR 2.476, 95%
CI 1.763-3.479, P<0.0001) and MACE (HR 1.569, 95%CI 1.206-2.042,
P¼0.0008).
Conclusions: Among patients with NSTEACS, diabetes was the independent
hazard factor of all-cause mortality and MACE. CABG can decrease all-cause
mortality and MACE of patients with NSTEACS with or without diabetes signif-
icantly, while PCI can only decrease MACE and wasn’t helpful for all-cause
mortality.GW25-e1652
The Changed Concentrations of Plasma Interleukin-18 and Tissue
Factor in Patients with Coronary Heart Disease after Percutaneous
Coronary Intervention
Li Qiaowen1, Jian Qiu2, Zhiliang Li3, Yunjun Ruan2, Xiaoyong Zhang1
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Objectives: To investigate the changed rule of interleukin-18 (IL-18), tissue factor
(TF) and their relationships in patients with coronary heart disease (CHD) after
percutaneous coronary intervention (PCI), and explore the alteration of inﬂammation
and coagulation in CHD patients after PCI.
Methods: The concentrations of plasma IL-18 and TF in patients with CHD were
measured by ELISA before PCI and after PCI immediately, 1d, 3d, 7d, 1m respec-
tively. Independent samples t-test was employed to analyze the distinction between 2
measured data. One-way ANOVA analysis was used to analyze the distinction
amoung 3 or more than 3 groups of measured data, linear correlation analysis was
used to the relationship between two measured variables.
Results: The concentrations of plasma IL-18 were 332.3114.3,
413.778.0,421.258.0,364.572.6,260.364.8,160.264.6 in patients with before
PCI and after PCI immediately,1d,3d,7d,1m respectively, The concentrations
of plasma TF were 102.220.5,116.113.4,118.29.1,105.615.7,86.011.7,
60.76.5. The concentrations of plasma IL-18 and TF in CHD patients were higher
after PCI immediately, The concentrations of plasma IL-18 in CHD patients after PCI
and in 1d after PCI were higher than that before PCI (P<0.05), they gradually
decreased in 3d after PCI (P<0.05), they were lower in 7d and 30d after PCI than that
before PCI (P<0.05) ; The concentrations of plasma TF were positively associated
with the concentrations of plasma IL-18 (P<0.01).
Conclusions: The higher concentrations of plasma TF, IL-18 were in the CHD pa-
tients and paralleled with the gravity of disease, the concentrations of plasma TF were
positively associated with the concentrations of plasma IL-18 before and after PCI,
this suggested that there were hypercoagulability activity and high inﬂammatory
response state in CHD patients. The inﬂammation and coagulation system closely
associate with each other.GW25-e0430
Thrombelastography (TEG) test to assess the anti-platelet therapy responsivity in
coronary heart disease
Zhao Yan, Yang Ming
Fuxing Hospital
Objectives: To assess the effect of combination anti-platelet therapy in patients with
coronary heart disease by using thrombelastography (TEG) and observing the9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
